CYBRD1 and breast cancer: Furthermore, there have been no reports on the activity of CLIP4, CAPN2, CRLF1, CYBRD1, PHF10, and TRHDE in breast cancer or chemoresistance, thus making them new candidates for understanding breast cancer, the EMT, and chemoresistance.